![Julie Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie Clark
Directeur Technique/Scientifique/R&D chez
4D MOLECULAR THERAPEUTICS, INC.
Profil
Julie Clark currently works at 4D Molecular Therapeutics, Inc., as Chief Medical Officer from 2025.
Dr. Clark also formerly worked at Regeneron Pharmaceuticals, Inc., as Associate Director-Medical affairs from 2011 to 2012, Novartis Corp., as Medical Director-Retina, Thrombogenics, Inc., as Medical Director, Adverum Biotechnologies, Inc., as Chief Medical Officer, IVERIC bio, Inc., as Vice President-Clinical Development, and Ceryvyn Therapeutics Ltd., as Senior Vice President-Clinical Development from 2024 to 2025.
Dr. Clark received her doctorate degree from Wake Forest School of Medicine, undergraduate degree from Wake Forest University, and graduate degree from The Johns Hopkins University.
Postes actifs de Julie Clark
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2025 |
Anciens postes connus de Julie Clark
| Sociétés | Poste | Fin |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | 01/07/2025 |
| ADVERUM BIOTECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 22/10/2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Directeur Technique/Scientifique/R&D | - |
Formation de Julie Clark
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Wake Forest School of Medicine
 Wake Forest School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
